MYONYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
MYOMO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$1.25+0.05 (+4.17%)
Close on Oct 19, 2026
- Market cap
- $53.37M
- P/E (TTM)
- –
- Dividend yield
- –
MYOMO, INC. revenue by segment
By business segment
By product or service
| Revenue | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | TTM Q1 23 | TTM Q4 22 | TTM Q3 22 | TTM Q2 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product revenue | $38.63M | $32.55M | $25.24M | $21.06M | $17.78M | $17.48M | $16.76M | $15.70M | $15.13M | $14.56M | $14.55M | $14.96M | 100.0% | +117.2% |
| License [Member] | – | $0 | – | – | – | $1.76M | $1.76M | $1.71M | $0 | $1.00M | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Myomo's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.